Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases

Sergio Recalde, Agustin Tortajada, Marta Subias, Jaouad Anter, Miquel Blasco, Ramona Maranta, Rosa Coco, Sheila Pinto, Marina Noris, Alfredo García-Layana, Santiago Rodríguez De Córdoba

Research output: Contribution to journalArticlepeer-review


The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa, a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.

Original languageEnglish
Pages (from-to)1305-1311
JournalJournal of the American Society of Nephrology : JASN
Issue number5
Publication statusPublished - 2016


  • Journal Article


Dive into the research topics of 'Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases'. Together they form a unique fingerprint.

Cite this